TesamorelinTSM5

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

Tesamorelin

Visceral fat and body composition

Tesamorelin specifications and reference prices. Select a specification to add it to your cart.

5mg/vial x 10vials
Reference priceUS$166.67

For laboratory research only. Not for human or veterinary use.

COA 检测报告 / Reports

Compare all specifications & reference prices
SKUSpecification / packReference price (USD)
TSM55mg/vial x 10vialsUS$166.67
TSM1010mg/vial x 10vialsUS$303.03
TSM2020mg/vial x 10vialsUS$575.76

Temporarily sold-out specifications can still be added to an inquiry to ask about restocking. An inquiry is not an order or an agreed price.

RESEARCH FOCUS

Main Uses & FAQs

This page organizes directly related information on Tesamorelin regarding visceral fat and body composition. First, look at research questions and findings, then verify the population or species, study formulations, and scope of interpretation.

Main TopicsVisceral Fat · Body Composition
USAGE REFERENCE

Tesamorelin · Usage reference (for research purposes)

The following presents common research-context references for reconstitution, storage, dosage and cycles. The following presents common references in research settings. This page does not constitute advice for use in humans or animals.

🧪Reconstitution

Suggested Diluent
Bacteriostatic Water (containing 0.9% benzyl alcohol); some peptides may use sterile water or acetic acid to aid dissolution. See the individual product descriptions.
Diluent Volume
Slowly introduce the diluent along the vial wall until the lyophilized powder is covered. A common example is 5 mg reconstituted with 2 mL of bacteriostatic water, yielding approximately 2.5 mg/mL. Referenced reconstitution volumes are approximately 1–2.5 mL, with 2 mL commonly used. It is suggested to select and record a fixed volume based on the COA supplied with the purchase.
Handling Notes
Introduce the diluent slowly along the vial wall rather than directly onto the lyophilized powder. Leave it for 60–90 seconds to dissolve naturally; do not shake vigorously.

💾Storage

Unreconstituted Lyophilized Powder
Refrigerate at 2–8°C, protected from light; avoid repeated freeze–thaw cycles.
After Reconstitution
Refrigerate at 2–8°C; a common recommendation is touse within 28 days; do not freeze.
Transport
For short periods, use insulated packaging with ice packs; avoid high temperatures and direct light.

📏Dosage Reference (Research)

Purpose / SettingCommon Reference
Administration RouteSubcutaneous Injection (Abdomen)
FrequencyOnce daily

🔁Cycle

Once-daily abdominal subcutaneous injection.

View the Complete Usage Guide Library →

Note: The above describes common research-context references, rather than clinical recommendations. Refer to the batch COA and research protocol. For research use only; not for human or animal use.

Research SummaryKey Findings

What research findings does Tesamorelin have regarding visceral fat and body composition?

Under integrase inhibitor treatment background, improvements in visceral fat, liver fat, and fat distribution indicators. Additionally, research reports: in responders, reduction in visceral fat and waist circumference was observed regardless of presence or absence of neck and back fat accumulation.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
3 Main ReferencesSorted by First Publication Date ↓
Human Study2024REF. 01

What changes occur in visceral fat in HIV under an integrase inhibitor background?

Research Findings

Under integrase inhibitor treatment background, improvements in visceral fat, liver fat, and fat distribution indicators.[1] ↗

Study Design

Human randomized trial subgroup; HIV-infected individuals

Scope & Limitations

Small sample subgroup of specific HIV populations.

View the Article Title and Full Citation+

Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors.

Russo SC, Ockene MW, Arpante AK, Johnson JE, Lee H, Toribio M, Stanley TL, Hadigan CM, Grinspoon SK, Erlandson KM, Fourman LT.

AIDS (London, England) · Volume/Issue Year 2024
First published 2024-06-20 · PMID 38905488
DOI 10.1097/qad.0000000000003965

Human Study2023REF. 02

How do responders’ fat distribution and waist circumference change?

Research Findings

Among responders, is there no neck and back fat accumulation, while visceral fat and waist circumference were reduced.[2] ↗

Study Design

Post hoc analysis of human Phase III trial

Scope & Limitations

Responder analysis; it cannot be inferred that it is effective for all subjects.

View the Article Title and Full Citation+

Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial.

Rahman F, McLaughlin T, Mesquita P, Morin J, Potvin D, De Chantal M, Aberg JA.

Journal of Clinical and Translational Science · Volume and Issue Year 2023
First published 2022-12-07 · PMID 36845310
DOI 10.1017/cts.2022.515

Human Study2021 · Historical basic researchREF. 03

Are fat quality and fat quantity the same indicator?

Research Findings

CT fat density improvement suggests changes in fat tissue quality.[3] ↗

Study Design

Human responder analysis of two randomized trials

Scope & Limitations

Surrogate indicators and responder selection; historical supplement in 2021.

View the Article Title and Full Citation+

Tesamorelin improves fat quality independent of changes in fat quantity.

Lake JE, La K, Erlandson KM, Adrian S, Yenokyan G, Scherzinger A, Dubé MP, Stanley T, Grinspoon S, Falutz J, Mamputu JC, Marsolais C, McComsey GA, Brown TT.

AIDS (London, England) · Volume/Issue Year 2021
First published 2021-07-01 · PMID 33756511
DOI 10.1097/qad.0000000000002897

i

Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

GO DEEPER

What Questions Do These Studies Address?

Compare study populations, findings and scope.

↗
QUESTIONS, ANSWERED

Tesamorelin · Frequently Asked Questions.

What research findings does Tesamorelin have regarding visceral fat and body composition?+

Under integrase inhibitor treatment background, improvements in visceral fat, liver fat, and fat distribution indicators. Additionally, research reports: in responders, reduction in visceral fat and waist circumference was observed regardless of presence or absence of neck and back fat accumulation.[1] ↗ [2] ↗

Is visceral fat research the same as general weight-loss research?+

Not equal. The page data mainly come from HIV-related abnormal fat distribution populations, observing visceral fat, waist circumference, or fat tissue indicators, and cannot be directly extrapolated to whole-body weight loss in healthy people.[1] ↗ [2] ↗

Tesamorelin—these conclusions apply to which study populations?+

Human randomized trial subgroup; HIV-infected individuals; Post-hoc analysis of Phase III human trials; Responder analysis of two human randomized trials. Small sample subgroup of specific HIV populations.[1] ↗ [2] ↗ [3] ↗

VENTRO PEPTIDES & BIOTECH · RESEARCH PRODUCT RETAIL

Research peptides. Shop by product.

Compare specifications, reference prices and COA reports. Add products to your cart to request a quote.

Ventro Peptides & Biotech Logo
QUALITY DOCUMENTSCOA BY PRODUCTGLOBAL DELIVERYTECHNICAL SUPPORT

01 / CATALOG

Browse products

7 products Product names, specifications, and prices follow the current quotation
SemaglutideSM10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Semaglutide

10mg/vial x 10vials

US$90.91
TirzepatideTR20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Tirzepatide

20mg/vial x 10vials

US$160.61
RetatrutideRT10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Retatrutide

10mg/vial x 10vials

US$109.09
BPC157BC10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Repair & Recovery Research

BPC157

10mg/vial x 10vials

US$133.33
MOTS-CMS20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Longevity & Mitochondrial Research

MOTS-C

20mg/vial x 10vials

US$257.58
LiraglutideLR10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Liraglutide

10mg*10vials

US$164.71
IGF-lr3IG1COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

IGF-lr3

1mg/vial x 10vials

US$505.88

03 / ABOUT VENTRO

Reliable peptide supply, built for long-term partnerships.

Ventro supports research product retail purchases with clear pack specifications, available quality documents, and responsive international support.

  • High-purity peptides
  • Available COA reports
  • COA & quality documentation
  • Flexible small-quantity purchases
  • Reliable global fulfillment
  • Research product retail support

04 / QUALITY SYSTEM

Quality without compromise

Browse the available COA reports by product. Confirm documentation for your order with our team.

Controlled quality workflowRaw material to final release
Responsive global supportProduct matching and technical support

RESEARCH PRODUCT INQUIRY

Submit a product inquiry

Tell us the product, specification, and expected quantity. Our team will respond with pricing and available documents.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

Contact Ventro

Choose a channel to contact the Ventro team directly.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

WhatsApp